characteristics.text: SAMN43302675
characteristics.characteristic: External Id
characteristics.text: Institute for Translational Medicine and Liver Disease (ITM)
characteristics.characteristic: INSDC center name
characteristics.text: 2024-11-28T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2024-11-28T22:01:03.964Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS22434473
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS22434473
characteristics.characteristic: SRA accession
characteristics.text: CD45+ immune cells
characteristics.characteristic: cell type
characteristics.text: missing
characteristics.characteristic: collection_date
characteristics.text: missing
characteristics.characteristic: geo_loc_name
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: Pancreatic ductal adenocarcinoma tumorspheroids
characteristics.characteristic: source_name
characteristics.text: Pancreatic ductal adenocarcinoma tumorspheroids
characteristics.characteristic: tissue
characteristics.text: TAK1 inhibitor-treated immune cells
characteristics.characteristic: title
characteristics.text: 5Z-7-oxozeaenol or DMSO
characteristics.characteristic: treatment